Daniella Beckman
2020
In 2020, Daniella Beckman earned a total compensation of $834.4K as Chief Financial Officer at Tango Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $131,828 |
|---|---|
| Option Awards | $368,323 |
| Salary | $323,447 |
| Other | $10,776 |
| Total | $834,374 |
Beckman received $368.3K in option awards, accounting for 44% of the total pay in 2020.
Beckman also received $131.8K in non-equity incentive plan, $323.4K in salary and $10.8K in other compensation.
Rankings
In 2020, Daniella Beckman's compensation ranked 9,335th out of 13,090 executives tracked by ExecPay. In other words, Beckman earned more than 28.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,335 out of 13,090 | 29th |
Division Manufacturing | 3,985 out of 5,621 | 29th |
Major group Chemicals And Allied Products | 1,619 out of 2,254 | 28th |
Industry group Drugs | 1,417 out of 1,954 | 28th |
Industry Pharmaceutical Preparations | 1,040 out of 1,459 | 29th |
Source: SEC filing on April 26, 2022.
Beckman's colleagues
We found two more compensation records of executives who worked with Daniella Beckman at Tango Therapeutics in 2020.